CMV reactivation may protect against relapse in HLA-C KIR ligand group homozygous but not heterozygous recipients following allogeneic peripheral blood stem cell transplantation

J Clausen; B Kircher; Jutta Auberger; P Schumacher; Christoph Grabmer; A Muhlbacher; G Gastl; D Nachbaur

CMV reactivation may protect against relapse in HLA-C KIR ligand group homozygous but not heterozygous recipients following allogeneic peripheral blood stem cell transplantation

J Clausen, B Kircher, Jutta Auberger, P Schumacher, Christoph Grabmer, A Muhlbacher, G Gastl, D Nachbaur

Universitätsklinik für Innere Medizin 3 - Hämatologie, internistische Onkologie, Hämostaseologie, Infektiologie, Rheumatologie und Onkologisches Zentrum

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

1 Quellenangabe (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	S275-S275
Fachzeitschrift	BONE MARROW TRANSPLANTATION
Jahrgang	47
Publikationsstatus	Veröffentlicht - 2012
Veranstaltung	38th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT) - Geneva, SWITZERLAND Dauer: 1 Apr. 2012 → 4 Apr. 2012

Dieses zitieren

@article{9ed8c09d0d654efcafe6c15dd9b96f88,

title = "CMV reactivation may protect against relapse in HLA-C KIR ligand group homozygous but not heterozygous recipients following allogeneic peripheral blood stem cell transplantation",

author = "J Clausen and B Kircher and Jutta Auberger and P Schumacher and Christoph Grabmer and A Muhlbacher and G Gastl and D Nachbaur",

year = "2012",

language = "English",

volume = "47",

pages = "S275--S275",

journal = "BONE MARROW TRANSPLANTATION",

issn = "0268-3369",

note = "38th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT) ; Conference date: 01-04-2012 Through 04-04-2012",

}

CMV reactivation may protect against relapse in HLA-C KIR ligand group homozygous but not heterozygous recipients following allogeneic peripheral blood stem cell transplantation. / Clausen, J; Kircher, B; Auberger, Jutta et al.
in: BONE MARROW TRANSPLANTATION, Jahrgang 47, 2012, S. S275-S275.

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

TY - JOUR

T1 - CMV reactivation may protect against relapse in HLA-C KIR ligand group homozygous but not heterozygous recipients following allogeneic peripheral blood stem cell transplantation

AU - Clausen, J

AU - Kircher, B

AU - Auberger, Jutta

AU - Schumacher, P

AU - Grabmer, Christoph

AU - Muhlbacher, A

AU - Gastl, G

AU - Nachbaur, D

PY - 2012

Y1 - 2012

M3 - Abstract (Journal)

SN - 0268-3369

VL - 47

SP - S275-S275

JO - BONE MARROW TRANSPLANTATION

JF - BONE MARROW TRANSPLANTATION

T2 - 38th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT)

Y2 - 1 April 2012 through 4 April 2012

ER -